Skip to content

The Effects of Noninvasive Neuromodulation on Mental Wellness, Behavior, and Electrophysiology

The Effects of Noninvasive Brain Stimulation on Mental States, Behavior, and Electrophysiology

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06169631
Enrollment
100
Registered
2023-12-13
Start date
2023-04-29
Completion date
2024-04-30
Last updated
2023-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders

Brief summary

The purpose of the study is to test the effects of brief, low-intensity transcranial focused ultrasound (TUS) on electrophysiological, behavioral, and cognitive markers related to anxiety disorders.

Detailed description

We will test the effects of TUS on self-reported and clinical anxiety states in healthy participants and in those with diagnosed anxiety disorders. Participants in these studies will receive pulsed TUS to the brain regions of interest. We will test whether multiple doses of TUS lead to larger reductions in mental states related to anxiety in comparison to a single dose of TUS.

Interventions

DEVICEGen0b

The ultrasound will be administered to the brain region of interest.

Sponsors

Sanmai Technologies PBC dba Sanmai
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Each experiment arm will have its own group(s).

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-65 years of age, as verified via photo identification with date of birth. * Should be an English speaker, as indicated by being able to read and comprehend the consent form. * Experiment 2 : Participants will be included for a past diagnosis of anxiety within the past year.

Exclusion criteria

* Smokes or uses tobacco products or any form of nicotine excessively * History of head injury with loss of consciousness for more than 5 min * Uncorrected hearing or vision impairment, including color blindness * Currently have or history of brain or mental illness judged likely to interfere with testing, including drug and/or alcohol dependence * History of epilepsy * Brain tumors * Takes medications or drugs judged likely to change brain activity, including psychoactive drugs, stimulants, benzodiazepines, and/or others * Factors that may lead to poor EEG or fNIRS recordings (e.g., hairstyle) * Inadequate sleep * Drug, alcohol or prescription drug intoxication, dependence or addiction * Pregnancy, or becoming pregnant during the course of the study * Mild cognitive impairment or impaired decision making * History of migraines * Experience with neurostimulation (which might unbind or alter the results) * Metal implants in their head or face

Design outcomes

Primary

MeasureTime frameDescription
Hamilton Anxiety Rating Inventory1 monthPsychological questionnaire used by clinicians to rate the severity of a patient's anxiety

Countries

United States

Contacts

Primary ContactLisannette A Ruiz
lisannette.r@sanm.ai520-343-1070
Backup ContactStephanie French
stephanie.f@sanm.ai650-417-8675

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026